Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
99.88
-1.03 (-1.02%)
Feb 11, 2026, 4:00 PM EST - Market closed
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $5.98 billion as of February 12, 2026. Its market cap has increased by 156.99% in one year.
Market Cap
5.98B
Enterprise Value
5.92B
1-Year Change
156.99%
Ranking
Category
Stock Price
$99.88
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $5.98B, an increase of 1,912.20%. That is a compound annual growth rate of 57.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 6.04B | 48.01% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.58B |
| Rhythm Pharmaceuticals | 6.57B |
| Belite Bio | 6.57B |
| ImmunityBio | 6.44B |
| Caris Life Sciences | 6.07B |
| PTC Therapeutics | 5.69B |
| Cogent Biosciences | 5.66B |
| Immunovant | 5.28B |